Showing results (131-140 of 208) with videos related to

Sort By:
Pageof 21
Frontiers in Immunology|December 17, 2020
Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19Karel F A Van Damme, Simon Tavernier, Nele Van Roy, et al.
JCI Insight|November 15, 2022
Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responsesSydney I Ramirez, Alba Grifoni, Daniela Weiskopf, et al.
The Journal of Clinical Investigation|March 23, 2023
Durability of immune responses to mRNA booster vaccination against COVID-19Prabhu S Arunachalam, Lilin Lai, Hady Samaha, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2021
Differential T cell reactivity to seasonal coronaviruses and SARS-CoV-2 in community and health care workersRicardo da Silva Antunes, Suresh Pallikkuth, Erin Williams, et al.
Biorxiv : the Preprint Server for Biology|January 14, 2021
Immunological memory to SARS-CoV-2 assessed for up to eight months after infectionJennifer M Dan, Jose Mateus, Yu Kato, et al.
Frontiers in Immunology|December 24, 2024
Booster COVID-19 mRNA vaccination ameliorates impaired B-cell but not T-cell responses in older adultsKohei Kometani, Takaaki Yorimitsu, Norihide Jo, et al.
Science (New York, N.Y.)|January 7, 2021
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infectionJennifer M Dan, Jose Mateus, Yu Kato, et al.
Cell Host & Microbe|January 11, 2024
Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variantRofhiwa Nesamari, Millicent A Omondi, Richard Baguma, et al.
Pageof 21